GlassScriptPhysician profile
Macy Duong
NPI 1871255240
$1,528.84
in general payments reported to CMS, 2019-2025
21 companies · $481 in 2025
The $481 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $92.69 · 2023: $172 · 2024: $784 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,227 · Education: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,227.16 |
| Education | $208.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $354.80 | 2023-2025 | Trodelvy |
| Daiichi Sankyo INC. | $172.47 | 2024-2025 | Enhertu |
| Astrazeneca Pharmaceuticals LP | $137.44 | 2024-2025 | Enhertu |
| Merck Sharp & Dohme LLC | $117.67 | 2022-2025 | Keytruda |
| Seagen INC. | $84.99 | 2024 | |
| Caris Mpi, INC. | $80.05 | 2025 | Mi Cancer Seek |
| Lilly USA, LLC | $74.54 | 2022-2024 | Verzenio, Jaypirca, Retevmo |
| Novartis Pharmaceuticals Corporation | $65.80 | 2024 | |
| Genentech USA, INC. | $62.30 | 2023-2024 | Phesgo, Perjeta, Tecentriq |
| Tempus Ai, INC | $53.86 | 2024-2025 | Xt Cdx |
| Stemline Therapeutics INC. | $51.99 | 2025 | Orserdu |
| Pfizer INC. | $44.95 | 2023-2024 | |
| Ferring Pharmaceuticals INC. | $33.61 | 2024-2025 | Adstiladrin |
| Abbvie INC. | $33.02 | 2025 | |
| Medtronic, INC. | $31.85 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $31.81 | 2025 | Zoladex |
| Urogen Pharma, INC. | $25.00 | 2025 | |
| Immunogen, INC. | $22.24 | 2023 | Elahere |
| Foundation Medicine, INC. | $20.28 | 2023 | Foundationone Liquid Cdx |
| Eisai INC. | $15.27 | 2024 | |
| Amgen INC. | $14.90 | 2023 | Xgeva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Macy Duong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.